ABPS GI Endoscopy flashcards
ABPS GI Endoscopy · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Split-dose bowel preparation
- Regimen dividing the total polyethylene glycol solution into two doses, with the second taken 4-6 hours before colonoscopy, improving cleansing and patient tolerability.
- Boston Bowel Preparation Scale
- Validated 0-3 scoring of each colon segment after washing, summed to a total of 0-9, with 2 or more per segment indicating adequate preparation.
- ASA physical status
- Classification of patient comorbidity from I (healthy) through VI (brain-dead donor); higher classes predict sedation risk and often prompt anesthesia involvement.
- Endocarditis prophylaxis indication
- Antibiotics before endoscopy only for high-risk cardiac conditions such as prosthetic valves, prior infective endocarditis, or certain unrepaired congenital heart disease.
- Moderate sedation
- Drug-induced depression of consciousness in which patients respond purposefully to verbal or light tactile stimulation while maintaining spontaneous ventilation and airway reflexes.
- Capnography monitoring
- Continuous measurement of exhaled carbon dioxide that detects hypoventilation earlier than pulse oximetry and is recommended during deep sedation.
- Flumazenil reversal
- Benzodiazepine antagonist given in 0.2 mg intravenous increments up to 1 mg; it may precipitate seizures in chronic users and requires monitoring for resedation.
- Fasting before sedation
- Minimum of 2 hours for clear liquids and 6 hours for light solids to reduce aspiration risk before procedural sedation.
- Prague classification
- System describing Barrett esophagus by circumferential and maximal extent of columnar mucosa above the gastroesophageal junction, measured in centimeters.
- Seattle biopsy protocol
- Four-quadrant jumbo biopsies every 1-2 cm along the Barrett segment, plus targeted biopsies of visible lesions, to detect dysplasia or cancer.
- Forrest classification
- Endoscopic grading of peptic ulcer stigmata: Ia spurting, Ib oozing, IIa visible vessel, IIb adherent clot, IIc flat spot, and III clean base.
- Los Angeles classification
- Grading of erosive esophagitis from A (mucosal breaks under 5 mm) to D (breaks involving at least 75 percent of the circumference).
- Adenoma detection rate
- Proportion of screening colonoscopies in which at least one adenoma is removed; benchmarks are 25 percent overall, 30 percent in men, and 20 percent in women.
- Cecal intubation landmarks
- Appendiceal orifice, ileocecal valve, and triradiate fold confirm complete colonoscopy; photographic documentation is a recognized quality metric.
- Post-polypectomy surveillance
- Interval based on findings: 1-2 low-risk adenomas 7-10 years; 3-4 adenomas or a lesion 10 mm or more 3 years; 5 or more or high-grade dysplasia 1 year.
- Epinephrine injection hemostasis
- Submucosal injection of dilute epinephrine at 1:10,000 producing vasoconstriction and tamponade; usually temporary and combined with a second modality.
- Through-the-scope clip
- Deployable metallic clip used to compress bleeding vessels or close small defects, preferred for visible vessels and high-risk ulcer stigmata.
- Variceal band ligation
- Endoscopic placement of rubber bands on esophageal varices, repeated every 2-4 weeks until eradication, combined with vasoactive therapy and antibiotics acutely.
- Hemostatic powder
- Inert mineral powder sprayed onto bleeding lesions to form a mechanical barrier, useful for malignant or diffuse bleeding refractory to clips.
- Post-ERCP pancreatitis prophylaxis
- Rectal indomethacin 100 mg, aggressive lactated Ringer hydration, and prophylactic pancreatic stent placement in high-risk patients reduce pancreatitis risk.
- Choledocholithiasis risk stratification
- Very strong predictors include a common bile duct stone on imaging or cholangitis; strong predictors include a dilated duct plus bilirubin above 1.8 mg/dL.
- Self-expandable metal stent
- Larger-diameter biliary stent with longer patency than plastic stents, preferred for malignant obstruction, available in covered and uncovered designs.
- EUS-guided FNA
- Fine-needle aspiration under endoscopic ultrasound guidance for cytologic sampling of pancreatic masses, lymph nodes, and subepithelial lesions.
- Cyst fluid CEA
- Carcinoembryonic antigen level in pancreatic cyst fluid; values above 192 ng/mL suggest a mucinous cyst rather than a serous or inflammatory cyst.
- Linear echoendoscope
- Ultrasound endoscope with a side-viewing array that allows needle passage through the working channel for aspiration and drainage procedures.
- Capsule endoscopy retention
- Failure of the video capsule to pass a stricture; risk is assessed with a patency capsule in patients with suspected small bowel stenosis.
- Double-balloon enteroscopy
- Deep small bowel endoscopy using a balloon-mounted overtube and scope to pleat the intestine, enabling biopsy, hemostasis, and dilation.
- Endoscopic submucosal dissection
- En bloc resection using submucosal injection and electrosurgical knives that allows curative removal of early gastrointestinal neoplasia regardless of lesion size.
- High-level disinfection
- Killing of all microorganisms except high numbers of bacterial spores, achieved by soaking endoscopes in glutaraldehyde or an equivalent agent.
- Duodenoscope reprocessing
- Requires meticulous manual cleaning of the elevator mechanism, high-level disinfection or sterilization, and often microbiologic surveillance culture under regulatory guidance.
- Colonoscopy perforation rate
- Approximately 0.1-0.2 percent for diagnostic colonoscopy and higher with therapeutic intervention, most often at the sigmoid or cecum.
- Informed consent documentation
- Recorded discussion of indication, benefits, risks, alternatives, and sedation plan, signed before the procedure and filed with the endoscopy report.